Marker Therapeutics, Inc. (MRKR): Price and Financial Metrics
Marker Therapeutics, Inc. (MRKR)
Today's Latest Price: $2.04 USD
Updated Jan 25 6:55pm
Add MRKR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
MRKR Stock Summary
- MRKR's price/sales ratio is 144.79; that's higher than the P/S ratio of 97.03% of US stocks.
- With a year-over-year growth in debt of 2,195.11%, Marker Therapeutics Inc's debt growth rate surpasses 98.99% of about US stocks.
- As for revenue growth, note that MRKR's revenue has grown 218.95% over the past 12 months; that beats the revenue growth of 97.18% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Marker Therapeutics Inc, a group of peers worth examining would be ACRS, BCDA, RESN, XAIR, and APTX.
- MRKR's SEC filings can be seen here. And to visit Marker Therapeutics Inc's official web site, go to www.markertherapeutics.com.
MRKR Stock Price Chart Interactive Chart >
MRKR Price/Volume Stats
| Current price | $2.04 | 52-week high | $3.35 |
| Prev. close | $2.05 | 52-week low | $1.32 |
| Day low | $1.98 | Volume | 252,700 |
| Day high | $2.05 | Avg. volume | 767,720 |
| 50-day MA | $1.68 | Dividend yield | N/A |
| 200-day MA | $1.86 | Market Cap | 97.97M |
Marker Therapeutics, Inc. (MRKR) Company Bio
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.
Loading social stream, please wait...